ArticleResearch square2025
Oral washes and tongue swabs for Xpert MTB/RIF Ultra-based tuberculosis diagnosis in people with and without the ability to make sputum.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
16 authors.
Funding
Abstract
Background: Oral samples show promise for tuberculosis (TB) diagnosis. Data from different samples and people with sputum scarce TB are limited. Methods: We assessed Xpert MTB/RIF Ultra (Ultra) in symptomatic people at clinics (Cohort A, n=891) or at antiretroviral therapy (ART)-initiation without syndromic preselection (Cohort B, n=258). In Cohort A, we collected oral washes (OWs) and, separately, tongue swabs (flocked, foam with heat). In Cohort B, we collected OWs, three flocked tongue swabs (comparing one with heat to two pooled swabs) and, separately, buccal swabs, periodontal brushes. We offered sputum induction and did different culture methods on a subset of Cohort B tongue swabs. Results: In Cohort A, Ultra on OWs, flocked tongue and foam swabs had sensitivities of 80% (95% confidence interval 56, 94), 59% (53, 65) and 65% (58, 72) and high specificities. In Cohort B, OWs and single heated swabs had 71% (42, 92) and 64% (35, 87) sensitivity, respectively. Pooled tongue swabs, buccal swabs and periodontal brushes had low sensitivities. MGIT960 had the highest sensitivity [64% (35, 87)] of culture methods. Oral sampling detected TB in sputum-scarce people [Cohort A: 25% (7/28) flocked and foam swab-positive; Cohort B: 18% (10/56) OW-, 23% (13/56) single flocked swab-positive]. In Cohort B, this would at least double the people with a positive Ultra result (sputum or oral) if induction were unavailable. Conclusion: Ultra on OWs or foam tongue swabs has higher sensitivity than other oral-based approaches and detects sputum-scarce TB, resulted in more people diagnosed compared to Ultra on expectorated sputum.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.